EP3755345 - COMPOSITIONS AND METHODS FOR PAIN AMELIORATION IN PATIENT POPULATION THAT SCORES HIGH ON THE PAIN CATASTROPHIZING SCALE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.12.2021 Database last updated on 02.11.2024 | |
Former | Request for examination was made Status updated on 27.11.2020 | ||
Former | The international publication has been made Status updated on 31.08.2019 | Most recent event Tooltip | 24.12.2021 | Application deemed to be withdrawn | published on 26.01.2022 [2022/04] | Applicant(s) | For all designated states Adynxx Sub, Inc 100 Pine Street, Suite 500 San Francisco, CA 94111 / US | [2021/01] | Inventor(s) | 01 /
MANNING, Donald C. c/o Adynxx, Inc. 100 Pine Street, Suite 500 San Francisco, California 94111 / US | 02 /
HARRIS, Scott c/o Adynxx, Inc. 100 Pine Street, Suite 500 San Francisco, California 94111 / US | 03 /
HEBERT, Kimberly c/o Adynxx, Inc. 100 Pine Street, Suite 500 San Francisco, California 94111 / US | 04 /
GONZALEZ, Dina c/o Adynxx, Inc. 100 Pine Street, Suite 500 San Francisco, California 94111 / US | 05 /
MAMET, Julien c/o Adynxx, Inc. 100 Pine Street, Suite 500 San Francisco, California 94111 / US | 06 /
MARTIN, William c/o Adynxx, Inc. 100 Pine Street, Suite 500 San Francisco, California 94111 / US | 07 /
ORR, Rick c/o Adynxx, Inc. 100 Pine Street, Suite 500 San Francisco, California 94111 / US | [2021/01] | Representative(s) | Cooley (UK) LLP 22 Bishopsgate London EC2N 4BQ / GB | [N/P] |
Former [2021/01] | Cooley (UK) LLP Dashwood 69 Old Broad Street London EC2M 1QS / GB | Application number, filing date | 19757019.5 | 25.02.2019 | [2021/01] | WO2019US19401 | Priority number, date | US201862634666P | 23.02.2018 Original published format: US 201862634666 P | [2021/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019165361 | Date: | 29.08.2019 | Language: | EN | [2019/35] | Type: | A1 Application with search report | No.: | EP3755345 | Date: | 30.12.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.08.2019 takes the place of the publication of the European patent application. | [2020/53] | Search report(s) | International search report - published on: | US | 29.08.2019 | Classification | IPC: | A61K31/7088, A61K31/713, C12N15/113 | [2021/01] | CPC: |
A61K31/713 (EP,US);
A61K31/7088 (EP);
A61P29/00 (EP);
C12N15/113 (EP);
C12N15/1136 (US);
C12N2310/13 (EP);
C12N2320/30 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/01] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR SCHMERZLINDERUNG IN EINER PATIENTENPOPULATION, DIE AUF DER SCHMERZKATASTROPHISIERUNGSSKALA HOHE WERTE AUFWEISEN | [2021/01] | English: | COMPOSITIONS AND METHODS FOR PAIN AMELIORATION IN PATIENT POPULATION THAT SCORES HIGH ON THE PAIN CATASTROPHIZING SCALE | [2021/01] | French: | COMPOSITIONS ET PROCÉDÉS POUR L'AMÉLIORATION DE LA DOULEUR DANS UNE POPULATION DE PATIENTS QUI PRÉSENTE DES SCORES ÉLEVÉS SUR L'ÉCHELLE DE CATASTROPHISATION DE LA DOULEUR | [2021/01] | Entry into regional phase | 01.09.2020 | National basic fee paid | 01.09.2020 | Search fee paid | 01.09.2020 | Designation fee(s) paid | 01.09.2020 | Examination fee paid | Examination procedure | 01.09.2020 | Examination requested [2020/53] | 11.04.2021 | Loss of particular rights, legal effect: Claims | 07.05.2021 | Despatch of communication of loss of particular rights: Claims {1} | 01.09.2021 | Application deemed to be withdrawn, date of legal effect [2022/04] | 22.09.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2022/04] | Fees paid | Penalty fee | Additional fee for renewal fee | 28.02.2021 | 03   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2017151644 (ADYNXX INC [US], et al) [Y] 1-2, 3/1-2 * ; paragraphs [0010],[0051],[0077] *; | [Y] - BURNS, L et al., "Pain catastrophizing as a risk factor for chronic pain after total knee arthroplasty: a systematic review", Journal of Pain Research, (20150105), vol. 8, pages 21 - 32, XP055632099 [Y] 1-2, 3/1-2 * ; page 5, 1st and 3rd paragraphs; DOI: 10.2147/JPR.S64730 * DOI: http://dx.doi.org/10.2147/JPR.S64730 | [A] - MAMET, J et al., "Intrathecal administration of AYX2 DNA decoy produces a long-term pain treatment in rat models of chronic pain by inhibiting the KLF6, KLF9, and KLF15 transcription factors", Molecular Pain, (20170904), vol. 13, pages 1 - 17, XP055632105 [A] 1-2, 3/1-2 DOI: http://dx.doi.org/10.1177/1744806917727917 |